URMC Research Network - Michelle Shayne

Find People

Michelle Shayne

Title	Assistant Professor
Institution	School of Medicine and Dentistry
Department	Medicine
Address	University of Rochester Medical Center School of Medicine and Dentistry 601 Elmwood Ave, Box 704 Rochester NY 14642

Awards And Honors

1995			Robert I. Weed Summer Research Fellowship in Hematology \| University of Rochester School of Medicine and Dentistry
2006			Honored by 3rd year residents in Medicine & Medicine-Pediatrics as faculty member they felt contributed most to education.
2008	-	2010	Lawrence A. Kohn Senior Teaching Fellow

Selected Publications

Shayne M, Quill TE. Oncologists responding to grief: comment on "nature and impact of grief over patient loss on oncologists' personal and professional lives"oncologists responding to grief. Arch Intern Med. 2012 Jun 25; 172(12):966-7.

View in: PubMed
Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH. Appropriate chemotherapy dosing for obese adult patients with cancer: american society of clinical oncology clinical practice guideline. J Clin Oncol. 2012 May 1; 30(13):1553-61.

View in: PubMed
Shayne M. Prognosis. Ann Intern Med. 2011 Nov 1; 155(9):645.

View in: PubMed
Roscoe JA, Perlis ML, Pigeon WR, O'Neill KH, Heckler CE, Matteson-Rusby SE, Palesh OG, Shayne M, Huston A. Few changes observed in polysomnographic-assessed sleep before and after completion of chemotherapy. J Psychosom Res. 2011 Dec; 71(6):423-8.

View in: PubMed
Banerjee S, Lin CF, Skinner KA, Schiffhauer LM, Peacock J, Hicks DG, Redmond EM, Morrow D, Huston A, Shayne M, Langstein HN, Miller-Graziano CL, Strickland J, O'Donoghue L, De AK. Heat shock protein 27 differentiates tolerogenic macrophages that may support human breast cancer progression. Cancer Res. 2011 Jan 15; 71(2):318-27.

View in: PubMed
Shayne M, Balducci L. Hematopoietic growth factors in older cancer patients. Cancer Treat Res. 2011; 157:383-402.

View in: PubMed
Khorana AA, Shayne M, Korones DN. Can literature enhance oncology training? A pilot humanities curriculum. J Clin Oncol. 2011 Feb 1; 29(4):468-71.

View in: PubMed
Tang P, Wang J, Hicks DG, Wang X, Schiffhauer L, McMahon L, Yang Q, Shayne M, Huston A, Skinner KA, Griggs J, Lyman G. A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer. Cancer Invest. 2010 Nov; 28(9):978-82.

View in: PubMed
Roscoe JA, O'Neill M, Jean-Pierre P, Heckler CE, Kaptchuk TJ, Bushunow P, Shayne M, Huston A, Qazi R, Smith B. An exploratory study on the effects of an expectancy manipulation on chemotherapy-related nausea. J Pain Symptom Manage. 2010 Sep; 40(3):379-90.

View in: PubMed
Lo SS, Khorana AA, Javle M, Simon S, Kiefer G, Rajasenan K, Wang H, Hantel A, Shayne M, Hwang J, Schmotzer A, Ramanathan RK. A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas. Oncology. 2010; 78(2):125-9.

View in: PubMed
Shayne M, Culakova E, Wolff D, Poniewierski MS, Dale DC, Crawford J, Lyman GH. Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy. Cancer. 2009 Nov 15; 115(22):5319-28.

View in: PubMed
Rao MV, Shayne M. Vitiligo in the affected breast during neo-adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat. 2009 Sep; 117(1):197-8.

View in: PubMed
Shayne M, Culakova E, Poniewierski MS, Wolff D, Dale DC, Crawford J, Lyman GH. Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy. Cancer. 2007 Oct 1; 110(7):1611-20.

View in: PubMed
Lyman GH, Shayne M. Granulocyte colony-stimulating factors: finding the right indication. Curr Opin Oncol. 2007 Jul; 19(4):299-307.

View in: PubMed
Aivado M, Spentzos D, Germing U, Alterovitz G, Meng XY, Grall F, Giagounidis AA, Klement G, Steidl U, Otu HH, Czibere A, Prall WC, Iking-Konert C, Shayne M, Ramoni MF, Gattermann N, Haas R, Mitsiades CS, Fung ET, Libermann TA. Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease. Proc Natl Acad Sci U S A. 2007 Jan 23; 104(4):1307-12.

View in: PubMed
Shayne M, Crawford J, Dale DC, Culakova E, Lyman GH. Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy. Breast Cancer Res Treat. 2006 Dec; 100(3):255-62.

View in: PubMed